Clinical Trial Update: Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sodium heparin for prophylaxis of venous thromboembolism in surgical patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Sodium Heparin (heparin sodium)

Snippet

Sponsor: Azidus Brasil | Conditions: Venous Thromboembolism | Phase 3 | Status: WITHDRAWN